Article info
PDFClinical and epidemiological research
Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-α blocking agents
- Eirik Hornes Halvorsen, Institute of Immunology, University of Oslo, Rikshospitalet University Hospital, Oslo, Norway; eirikhha{at}rr-research.no
Citation
Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-α blocking agents
Publication history
- Accepted August 8, 2008
- First published August 22, 2008.
Online issue publication
May 04, 2023
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and European League Against Rheumatism